Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Andreas Joerg Mahl
Introduction
Andreas Joerg Mahl is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on the development of innovative combinations of therapies that aim to improve patient outcomes.
Latest Patents
Mahl holds a patent for "Combinations of FGFR4 inhibitors and bile acid sequestrants." This invention relates to a pharmaceutical combination that includes an FGFR4 inhibitor and a bile acid sequestrant. The patent outlines the use of this combination in the treatment of cancer and highlights the potential of bile acid sequestrants to reduce or mitigate side effects associated with FGFR4 inhibition therapy.
Career Highlights
Andreas Joerg Mahl is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approach to combining therapies showcases his commitment to advancing cancer treatment.
Collaborations
Mahl has collaborated with notable colleagues, including Robin Alec Fairhurst and Diana Graus Porta. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Andreas Joerg Mahl's contributions to pharmaceutical innovation, particularly in cancer treatment, demonstrate his expertise and dedication to improving patient care. His patent for the combination of FGFR4 inhibitors and bile acid sequestrants is a testament to his impactful work in the field.